About
About Shionogi
Who we are
Heritage
Global affiliates and locations
Shionogi BV - tax strategy
Transparency
Investor Relations
Grants and Donations
Sustainability
Innovation
Innovation
Our areas of focus
Our Partners
Drug Discovery
Antimicrobial Resistance
News
Investors
Careers
Contact
Europe
Worldwide
HOME
News
2023
Medicines Patent Pool to produce generic versions of Shionogi Oral antiviral
Release
Medical News
2023/06/26
Seven manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Shionogi's COVID-19 oral antiviral ensitrelvir to increase access in low and middle-income countries